Page last updated: 2024-10-28

hydroxychloroquine and Thyroiditis, Subacute

hydroxychloroquine has been researched along with Thyroiditis, Subacute in 1 studies

Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.

Thyroiditis, Subacute: Spontaneously remitting inflammatory condition of the THYROID GLAND, characterized by FEVER; MUSCLE WEAKNESS; SORE THROAT; severe thyroid PAIN; and an enlarged damaged gland containing GIANT CELLS. The disease frequently follows a viral infection.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Asfuroglu Kalkan, E1
Ates, I1

Other Studies

1 other study available for hydroxychloroquine and Thyroiditis, Subacute

ArticleYear
A case of subacute thyroiditis associated with Covid-19 infection.
    Journal of endocrinological investigation, 2020, Volume: 43, Issue:8

    Topics: Adult; Anti-Inflammatory Agents; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; C

2020